melatonin has been researched along with Severe Acute Respiratory Syndrome in 2 studies
Severe Acute Respiratory Syndrome: A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehrzadi, S | 1 |
| Karimi, MY | 1 |
| Fatemi, A | 1 |
| Reiter, RJ | 2 |
| Hosseinzadeh, A | 1 |
| Shiu, SY | 1 |
| Tan, DX | 1 |
| Pang, SF | 1 |
1 review available for melatonin and Severe Acute Respiratory Syndrome
| Article | Year |
|---|---|
SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.
Topics: Aged; Animals; Antioxidants; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Huma | 2021 |
1 other study available for melatonin and Severe Acute Respiratory Syndrome
| Article | Year |
|---|---|
Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug?
Topics: Anti-Inflammatory Agents; Antioxidants; Humans; Melatonin; Severe Acute Respiratory Syndrome | 2003 |